Amylyx Pharmaceuticals (AMLX)
Developing avexitide-led therapies for endocrine and neurodegenerative diseases.
$31.80
vs last close−1.20 (−3.65%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
−$0.38
Revenue estimate
$59.4K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.55−$0.42−$0.46−$0.37−$0.30−$0.37−$0.39Pending
Estimate−$0.49−$0.45−$0.44−$0.43−$0.31−$0.34−$0.36−$0.38
Surprise−12.2%+6.7%−4.5%+14.0%+3.2%−8.8%−8.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$665.0K——————Pending
Estimate———$52.0K−$52.0K——$59.4K
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.36 | — | — |
| Sep 2027 | −$0.36 | — | — |
| Jun 2027 | −$0.36 | — | — |
| Mar 2027 | −$0.37 | — | — |
| Dec 2026 | −$0.37 | — | — |
| Nov 2026 | −$0.38 | — | — |
| Aug 2026 | −$0.36 | −$0.39 | −8.1% |
| May 2026 | −$0.34 | −$0.37 | −8.8% |
| Mar 2026 | −$0.31 | −$0.30 | +3.2% |
| Nov 2025 | −$0.43 | −$0.37 | +14.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Jan 2022 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.36 | — | — | $17.1M | — | — | — |
| Sep 2027 | −$0.36 | — | — | $8.5M | — | — | — |
| Jun 2027 | −$0.36 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.37 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.37 | — | — | $0 | — | — | — |
| Nov 5, 2026 | −$0.38 | — | — | $59.4K | — | — | — |
| Aug 6, 2026 | −$0.36 | −$0.39 | −8.1% | — | — | — | +10.7% |
| May 7, 2026 | −$0.34 | −$0.37 | −8.8% | — | — | — | −5.4% |
| Mar 3, 2026 | −$0.31 | −$0.30 | +3.2% | −$52.0K | — | — | −7.8% |
| Nov 6, 2025 | −$0.43 | −$0.37 | +14.0% | $52.0K | — | — | −5.9% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 4, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 10, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 13, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Jan 10, 2022 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 |